Taurine as a Potential Treatment for Cellular Aging and Chronic Inflammation in Long COVID: A Systematic Review and Meta-Analysis - Takeaways - MDSpire

Taurine as a Potential Treatment for Cellular Aging and Chronic Inflammation in Long COVID: A Systematic Review and Meta-Analysis

  • By

  • Kaiming Wang

  • Chen Hsiang Ma

  • Mobin Khoramjoo

  • Janice Y. Kung

  • Gavin Y. Oudit

  • March 10, 2026

  • 0 min

Share

  • 1

    Long COVID affects 6% to 30% of COVID-19 survivors, leading to persistent symptoms and significant health consequences.

  • 2

    Taurine is a conditionally essential amino acid that may alleviate symptoms of long COVID due to its role in cellular energetics and inflammation.

  • 3

    Higher plasma taurine levels correlate with fewer long COVID symptoms, suggesting its potential as a therapeutic target.

  • 4

    This systematic review aims to evaluate taurine supplementation's efficacy and safety in treating conditions related to long COVID.

  • 5

    No studies have directly assessed taurine supplementation in long COVID patients, highlighting a gap in current research.

Original Source(s)

Taurine as a Potential Treatment for Cellular Aging and Chronic Inflammation in Long COVID: A Systematic Review and Meta-Analysis

  • by Kaiming Wang, Chen Hsiang Ma, Mobin Khoramjoo, Janice Y. Kung, Gavin Y. Oudit

  • March 10, 2026

Related Content

Reporting of Telehealth Implementation in Cystic Fibrosis: Scoping Review Using a Novel Theory-Based Evaluation Lens

De novo COVID-19-associated insulin resistance drives dysregulated neutrophil extracellular trap formation (NETosis) four months after infection

Jonathan Van-Tam on COVID’s Next Phase

Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19